Organization
Hobart, Australia
2 abstracts
Abstract
Trastuzumab emtansine (T-DM1) in advanced cancers with HER2 mutations or amplification: Results from the Molecular Screening and Therapeutics (MoST) Program substudy.Org: NHMRC Clinical Trials Centre, The University of Sydney, Sydney, NSW, Australia, Sydney, Australia, Garvan Institute of Medical Research,
Abstract
ASSOCIATION BETWEEN METABOLIC SYNDROME AND KNEE PAIN IN MIDDLE-AGED ADULTS OVER 10-13 YEARSOrg: University of Tasmania, Menzies Institute for Medical Research, Hobart, Australia, Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia, Hobart, Australia,